A abetalipoproteinemia/hipobetalipoproteinemia familiar homozigótica (ABL/HoFHBL) é uma forma grave de hipobetalipoproteinemia familiar. É caracterizada por níveis permanentemente muito baixos (abaixo do 5º percentil, o que significa que estão entre os mais baixos encontrados na população) de apolipoproteína B e colesterol LDL (o "colesterol ruim"), além de atraso no crescimento, má absorção de nutrientes, hepatomegalia (fígado aumentado) e problemas neurológicos e neuromusculares.
Introdução
O que você precisa saber de cara
A abetalipoproteinemia/hipobetalipoproteinemia familiar homozigótica (ABL/HoFHBL) é uma forma grave de hipobetalipoproteinemia familiar. É caracterizada por níveis permanentemente muito baixos (abaixo do 5º percentil, o que significa que estão entre os mais baixos encontrados na população) de apolipoproteína B e colesterol LDL (o "colesterol ruim"), além de atraso no crescimento, má absorção de nutrientes, hepatomegalia (fígado aumentado) e problemas neurológicos e neuromusculares.
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 32 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 69 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.
Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid between phospholipid surfaces (PubMed:15897609, PubMed:16478722, PubMed:22236406, PubMed:23475612, PubMed:25108285, PubMed:26224785, PubMed:8876250, PubMed:8939939). Required for the assembly and secretion of plasma lipoproteins that contain apolipoprotein B (PubMed:16478722, PubMed:23475612, PubMed:26224785, PubMed:8876250, PubMed:8939939). May be involved in regulating cholesteryl ester biosynthesis in cells that prod
Endoplasmic reticulumGolgi apparatus
Abetalipoproteinemia
An autosomal recessive disorder of lipoprotein metabolism. Affected individuals produce virtually no circulating apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL, lipoprotein(A)). Malabsorption of the antioxidant vitamin E occurs, leading to spinocerebellar and retinal degeneration.
Variantes genéticas (ClinVar)
209 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
3 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Abetalipoproteinemia
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
Pesquisa e ensaios clínicos
5 ensaios clínicos encontrados.
Publicações mais relevantes
Genetic dyslipidemias.
Although genetic factors strongly influence lipid metabolism, genetic dyslipidemias refer to specific monogenic defects that significantly alter the function of proteins involved in lipid metabolism. Familial hypercholesterolemia results from mutations in the genes coding for LDL receptor, apolipoprotein B100 (apoB100), PCSK9, or LDLRAP1. The rare homozygous form is severe, with extravascular lipid deposits at an early age and a high incidence of coronary events in childhood, in the absence of early diagnosis. The heterozygous form is more frequent and characterized by elevated plasma LDL cholesterol levels (>190 mg/dL in adults) and a very high risk of premature coronary artery disease (usually before the age of 50 years). Familial chylomicronemia syndrome (FCS) is a major form of genetic hypertriglyceridemia caused by mutations in genes encoding lipoprotein lipase or one of its cofactors (apoC-II, apoA-V, GPIHBP1, or LMF1). Patients with FCS exhibit markedly elevated plasma triglyceride levels (>10 mmol/L) and are at high risk for acute pancreatitis. Congenital familial partial lipodystrophy and glycogen storage diseases are two other forms of genetic hypertriglyceridemia. In addition, other rare genetic dyslipidemias have been described in humans, including familial dysbetalipoproteinemia, abetalipoproteinemia, familial hypobetalipoproteinemia, familial combined hypolipidemia, sitosterolemia, and hypoalphalipoproteinemias.
The Role of Visual Electrophysiology in Systemic Hereditary Syndromes.
Visual electrophysiology is a valuable tool for evaluating the visual system in various systemic syndromes. This review highlights its clinical application in a selection of syndromes associated with hearing loss, mitochondrial dysfunction, obesity, and other multisystem disorders. Techniques such as full-field electroretinography (ffERG), multifocal electroretinography (mfERG), pattern electroretinography (PERG), visual evoked potentials (VEP), and electrooculography (EOG) offer insights into retinal and optic nerve function, often detecting abnormalities before clinical symptoms manifest. In hearing loss syndromes like Refsum disease, Usher syndrome (USH), and Wolfram syndrome (WS), electrophysiology facilitates the detection of early retinal changes that precede the onset of visual symptoms. For mitochondrial disorders such as maternally-inherited diabetes and deafness (MIDD), Kearns-Sayre syndrome (KSS), and neuropathy, ataxia, and retinitis pigmentosa (NARP) syndrome, these tests can be useful in characterizing retinal degeneration and optic neuropathy. In obesity syndromes, including Bardet-Biedl syndrome (BBS), Alström syndrome, and Cohen syndrome, progressive retinal degeneration is a hallmark feature. Electrophysiological techniques aid in pinpointing retinal dysfunction and tracking disease progression. Other syndromes, such as Alagille syndrome (AGS), abetalipoproteinemia (ABL), Cockayne syndrome (CS), Joubert syndrome (JS), mucopolysaccharidosis (MPS), Neuronal ceroid lipofuscinoses (NCLs), and Senior-Løken syndrome (SLS), exhibit significant ocular involvement that can be evaluated using these methods. This review underscores the role of visual electrophysiology in diagnosing and monitoring visual system abnormalities across a range of syndromes, potentially offering valuable insights for early diagnosis, monitoring of progression, and management.
Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation.
Background: The long-term clinical and laboratory results of a 33-year follow-up of a Greek family with abetalipoproteinemia (ABL) are described. Case Report: The patients (two brothers and their sister, aged 57, 49, and 62 years, respectively) are still alive, being under close surveillance. In two of the three patients, diarrhea appeared in early infancy, while in the third, it appeared during adolescence. CNS symptomatology worsened after the second decade of life. At the same time, night blindness appeared in the advanced stages of the disease, resulting in almost complete loss of vision in one of the male patients and severe impairment in the other. The diagnosis was based on the clinical picture, ophthalmological findings, serum lipid estimations, and presence of peripheral acanthocytosis. All patients exhibited typical serum lipidemic profile, ophthalmological findings, and acanthocytes in the peripheral blood. During the follow-up period, strict dietary modifications were applied, including the substitution of fat with medium-chain triglycerides (MCT oil). After 33 years since the initial diagnosis, all patients are alive without any sign of liver dysfunction despite continuous use of MCT oil. However, symptoms from the central nervous system and vision impairment worsened. Conclusion: The course of these patients suggests that the application of a modified diet, including MCT oil, along with close surveillance, could prolong the survival of patients without significant side effects from the liver.
Delayed Tricep Repair Using Dermal Allograft: Technique and Case Examples.
An acellular dermal matrix is a biological graft composed of several components present in the dermis such as collagen fibers, elastin, fibronectin, and hyaluronic acid that serve as support for cellular repopulation that will gradually become vascularized. This provides mechanical resistance and improves suture retention. With this article we aim to present 2 cases, and our technique, in which a rupture of the distal triceps tendon occurred, patients presented late due to usual insurance authorization delays, and then required delayed surgical repair by means of dermal acellular matrix grafting in order to bridge the substantial gap due to tricep proximal retraction. The first case report describes a 55-year-old male with abetalipoproteinemia who suffered an unclear injury to his right triceps tendon and apparently an olecranon bursitis and/or tricep tendonitis. Surgical intervention involved exploring the triceps tendon, revealing degenerative tissue and a detached muscle belly that was unrepairable, necessitating immediate reconstruction with a dermal allograft. The poor quality of the triceps tendon, weakened by cortisone injections, precluded primary repair, highlighting the rationale for graft reconstruction. The second case concerns a 54-year-old male, a gym owner and amateur bodybuilder, who suffered a fracture of the lateral epicondyle with avulsion of the distal triceps following a motorcycle accident. The patient underwent surgery with end-to-end suturing of the tendon and augmentation of the suture using acellular dermal matrix. The successful use of a dermal allograft in surgical reconstruction presents a promising solution in cases with insufficient tendon quality.
Binding of Selected Ligands to Human Protein Disulfide Isomerase and Microsomal Triglyceride Transfer Protein Complex and the Associated Conformational Changes: A Computational Molecular Modelling Study.
Human protein disulfide isomerase (PDI) is a multifunctional protein, and also serves as the β subunit of the human microsomal triglyceride transfer protein (MTP) complex, a lipid transfer machinery. Dysfunction of the MTP complex is associated with certain disease conditions such as abetalipoproteinemia and cardiovascular diseases. It is known that the functions of PDI or the MTP complex can be regulated by the binding of a small-molecule ligand to either of these two proteins. In the present study, the conformational changes of the MTP complex upon the binding of three selected small-molecule ligands (17β-estradiol, lomitapide and a phospholipid) are investigated based on the available biochemical and structural information by using the protein-ligand docking method and molecular dynamics (MD) simulation. The ligand-binding sites, the binding poses and binding strengths, the key binding site residues, and the ligand binding-induced conformational changes in the MTP complex are analyzed based on the MD trajectories. The open-to-closed or closed-to-open transitions of PDI is found to occur in both reduced and oxidized states of PDI and also independent of the presence or absence of small-molecule ligands. It is predicted that lomitapide and 1,2-diacyl-sn-glycero-3-phosphocholine (a phospholipid) can bind inside the lipid-binding pocket in the MTP complex with high affinities, whereas 17β-estradiol interacts with the lipid-binding pocket in addition to its binding to the interface region of the MTP complex. Additionally, lomitapide can bind to the b' domain of PDI as reported earlier for E2. Key residues for the ligand-binding interactions are identified in this study. It will be of interest to further explore whether the binding of small molecules can facilitate the conformational transitions of PDI in the future. The molecular and structural insights gained from the present work are of value for understanding some of the important biological functions of PDI and the MTP complex.
Publicações recentes
Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation.
Atypical retinopathy as an important clue for abetalipoproteinemia diagnosis in a low-income setting.
Delayed Tricep Repair Using Dermal Allograft: Technique and Case Examples.
The Role of Visual Electrophysiology in Systemic Hereditary Syndromes.
📚 EuropePMC213 artigos no totalmostrando 100
Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation.
Journal of personalized medicineAtypical retinopathy as an important clue for abetalipoproteinemia diagnosis in a low-income setting.
Oman journal of ophthalmologyDelayed Tricep Repair Using Dermal Allograft: Technique and Case Examples.
Techniques in hand & upper extremity surgeryThe Role of Visual Electrophysiology in Systemic Hereditary Syndromes.
International journal of molecular sciencesBinding of Selected Ligands to Human Protein Disulfide Isomerase and Microsomal Triglyceride Transfer Protein Complex and the Associated Conformational Changes: A Computational Molecular Modelling Study.
ChemistryOpenSyndromic retinitis pigmentosa.
Progress in retinal and eye researchA novel mutation, Ile344Asn, in microsomal triglyceride transfer protein abolishes binding to protein disulfide isomerase.
Journal of lipid researchAbetalipoproteinemia with angioid streaks, choroidal neovascularization, atrophy, and extracellular deposits revealed by multimodal retinal imaging.
Ophthalmic geneticsHigh carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population.
Journal of clinical lipidologyA New Case of Abetalipoproteinemia Caused by Novel Compound Heterozygote Mutations in the MTTP Gene without Fat or Vitamin Malabsorption.
Journal of atherosclerosis and thrombosisCurrent Diagnosis and Management of Familial Hypobetalipoproteinemia 1.
Journal of atherosclerosis and thrombosisUnique Genetic Features of Lean NAFLD: A Review of Mechanisms and Clinical Implications.
Journal of clinical and translational hepatologyDeep brain stimulation in Bassen-Kornzweig syndrome: Still effective after 22 years.
Brain & spineCarotenoids in familial hypobetalipoproteinemia disorders: Malabsorption in Caco2 cell models and severe deficiency in patients.
Journal of clinical lipidologyInborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.
CellsAcanthocytosis: a key feature for the diagnosis of abetalipoproteinemia.
BloodUnusual Presentation of Cow's Milk Protein Allergy.
JPGN reportsRare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal.
Frontiers in geneticsLow cholesterol states: clinical implications and management.
Expert review of endocrinology & metabolismA Rare Case of Ophthalmoplegia with Ataxia in Genetically Proven Abetalipoproteinemia.
Movement disorders clinical practiceMarked Acanthocytosis Associated With Klipple Trenaunay Syndrom.
Journal of Ayub Medical College, Abbottabad : JAMCValidation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias.
Nutrients[Homozygous familial hypobetalipoproteinemia caused by APOB gene variations: a case report and review of literature].
Zhonghua er ke za zhi = Chinese journal of pediatricsGuidance for the diagnosis and treatment of hypolipidemia disorders.
Journal of clinical lipidology[A case of primary ciliary dyskinesia and abetalipoproteinaemia].
Zhonghua er ke za zhi = Chinese journal of pediatricsTreatable Ataxias: How to Find the Needle in the Haystack?
Journal of movement disordersGeneration of hepatoma cell lines deficient in microsomal triglyceride transfer protein.
Journal of lipid researchMolecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.
Advances in experimental medicine and biologyCongenital disorders of intestinal digestion and absorption (sugars, proteins, lipids, ions).
Best practice & research. Clinical gastroenterologyForty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins.
Journal of clinical lipidologyAcanthocytosis in an alectinib-treated patient.
British journal of haematologyProspective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design.
Journal of atherosclerosis and thrombosisZebrafish mutants provide insights into Apolipoprotein B functions during embryonic development and pathological conditions.
JCI insight17β-Estradiol-Induced Conformational Changes of Human Microsomal Triglyceride Transfer Protein: A Computational Molecular Modelling Study.
CellsAbetalipoproteinemia Due to a Novel Splicing Variant in MTTP in 3 Siblings.
Journal of investigative medicine high impact case reportsNormal plasma apoB48 despite the virtual absence of apoB100 in a compound heterozygote with novel mutations in the MTTP gene.
Journal of clinical lipidologyHypotriglyceridemias/hypolipidemias.
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de ArteriosclerosisCurrent Diagnosis and Management of Abetalipoproteinemia.
Journal of atherosclerosis and thrombosisLipids Responsible for Intestinal or Hepatic Disorder: When to Suspect a Familial Intestinal Hypocholesterolemia?
Journal of pediatric gastroenterology and nutritionAlectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide binding.
PathologySuccessful Nutritional Intervention for an Infant with Abetalipoproteinemia: A Novel Modular Formula (AbetaMF).
JPGN reportsNew Classification and Management of Abetalipoproteinemia and Related Disorders.
GastroenterologyA novel p.Gly417Valfs*12 mutation in the MTTP gene causing abetalipoproteinemia: Presentation of the first patient in Mexico and analysis of the previously reported cases.
Journal of clinical laboratory analysis2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
Arteriosclerosis, thrombosis, and vascular biologyRare Diseases Related with Lipoprotein Metabolism.
Advances in experimental medicine and biologyMicrosomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic Diseases.
Advances in experimental medicine and biologyVitamin-Responsive Movement Disorders in Children.
Annals of Indian Academy of NeurologyChronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case Series.
Journal of clinical immunologyAn Unusual Presentation of Hemorrhagic Disease in an Infant: A Probable Case of Abetalipoproteinemia.
Journal of pediatric hematology/oncologyWhite-Out Duodenal Mucosa: Clue to a Systemic Diagnosis.
GastroenterologyNovel MTTP Gene Mutation in a Case of Abetalipoproteinemia with Central Hypothyroidism.
Journal of clinical research in pediatric endocrinologyHypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease.
Current opinion in lipidologyNovel mutations of SAR1B gene in four children with chylomicron retention disease.
Journal of clinical lipidologyTwo infants with abetalipoproteinemia: Classic versus atypical presentation.
Pediatrics international : official journal of the Japan Pediatric SocietyBruising as the first sign of exocrine pancreatic insufficiency in infancy.
Medicine and pharmacy reportsImpaired Chylomicron Assembly Modifies Hepatic Metabolism Through Bile Acid-Dependent and Transmissible Microbial Adaptations.
Hepatology (Baltimore, Md.)Acanthocytosis causing chronic hemolysis in a patient with advanced cirrhosis.
BloodNormal serum ApoB48 and red cells vitamin E concentrations after supplementation in a novel compound heterozygous case of abetalipoproteinemia.
AtherosclerosisMolecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.
AtherosclerosisOphthalmic diagnosis and optical coherence tomography of abetalipoproteinemia, a treatable form of pediatric retinal dystrophy.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and StrabismusAcanthocytosis and brain damage in area postrema and choroid plexus: Description of novel signs of Loxosceles apachea envenomation in rats.
PloS onePhotoinactivation of Neisseria gonorrhoeae: A Paradigm-Changing Approach for Combating Antibiotic-Resistant Gonococcal Infection.
The Journal of infectious diseasesPostprandial lipid absorption in seven heterozygous carriers of deleterious variants of MTTP in two abetalipoproteinemic families.
Journal of clinical lipidologyAbetalipoproteinemia From Previously Unreported Gene Mutations.
Annals of internal medicineA Thorny Finding: Unexpected Acanthocytosis in an Elderly Patient.
Clinical chemistryMarked acanthocytosis in the setting of Klippel-Trenaunay syndrome: A case report.
International journal of laboratory hematologyAcanthocytosis in progressive childhood dystonia.
Neurology IndiaEfficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.
Journal of lipid researchLaboratory investigations.
Handbook of clinical neurologyNew pathogenic mutation of chorea-acanthocytosis.
NeurologiaProgress in the Diagnosis and Management of Chorea-acanthocytosis.
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chihComplex genetic architecture in severe hypobetalipoproteinemia.
Lipids in health and diseaseAbsence of Acanthocytosis in Huntington's Disease-like 2: A Prospective Comparison with Huntington's Disease.
Tremor and other hyperkinetic movements (New York, N.Y.)Causes Of Chronic Non-Infectious Diarrhoea In Infants Less Than 6 Months Of Age: Rarely Recognized Entities.
Journal of Ayub Medical College, Abbottabad : JAMCLack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress.
Cell reportsExtending the aceruloplasminemia phenotype: NBIA on imaging and acanthocytosis, yet only minor neurological findings.
Journal of the neurological sciencesA tale of 2 cousins: An atypical and a typical case of abetalipoproteinemia.
Journal of clinical lipidologyStructure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects.
Biochimica et biophysica actaIdentification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia.
AtherosclerosisMicrosomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up.
Indian journal of gastroenterology : official journal of the Indian Society of GastroenterologyChylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.
Clinica chimica acta; international journal of clinical chemistryHYPERGLYCAEMIC HEMIBALLISMUS: IMPLICATIONS FROM CONNECTIVITY ANALYSIS FOR COGNITIVE IMPAIRMENTS.
Ideggyogyaszati szemleThe role of enterocyte defects in the pathogenesis of congenital diarrheal disorders.
Disease models & mechanismsHypolipidemia in a Special Operations Candidate: Case Report and Review of the Literature.
Journal of special operations medicine : a peer reviewed journal for SOF medical professionalsHomozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.
Clinica chimica acta; international journal of clinical chemistryUpdate on the molecular biology of dyslipidemias.
Clinica chimica acta; international journal of clinical chemistryFinding the Therapeutic Sweet Spot: Using Naturally Occurring Human Variants to Inform Drug Design.
Circulation. Cardiovascular geneticsMTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study.
BMC medical geneticsA Male Infant with Abetalipoproteinemia: A Case Report from Iran.
Middle East journal of digestive diseasesMicrosomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide.
The Journal of biological chemistryNovel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function.
Circulation. Cardiovascular geneticsHow low is too low: Statin induced hemolysis.
American journal of hematologyVitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia.
Free radical biology & medicineThe Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations.
Journal of clinical lipidologyFat accumulation in enterocytes: a key to the diagnosis of abetalipoproteinemia or homozygous hypobetalipoproteinemia.
EndoscopyMacular atrophy in a case of abetalipoproteinemia as only ocular clinical feature.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologieAcanthocytosis and the c.680 A>G Mutation in the PANK2 Gene: A Study Enrolling a Cohort of PKAN Patients from the Dominican Republic.
PloS oneExtreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia.
JIMD reportsHomozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature.
AtherosclerosisContemporary aspects of the biology and therapeutic regulation of the microsomal triglyceride transfer protein.
Circulation researchAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Abetalipoproteinemia.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Abetalipoproteinemia
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Genetic dyslipidemias.
- The Role of Visual Electrophysiology in Systemic Hereditary Syndromes.
- Thirty-Three Years Follow-Up of a Greek Family with Abetalipoproteinemia: Absence of Liver Damage on Long-Term Medium Chain Triglycerides Supplementation.
- Delayed Tricep Repair Using Dermal Allograft: Technique and Case Examples.
- Binding of Selected Ligands to Human Protein Disulfide Isomerase and Microsomal Triglyceride Transfer Protein Complex and the Associated Conformational Changes: A Computational Molecular Modelling Study.
- Atypical retinopathy as an important clue for abetalipoproteinemia diagnosis in a low-income setting.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:14(Orphanet)
- OMIM OMIM:200100(OMIM)
- MONDO:0008692(MONDO)
- GARD:5(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Artigo Wikipedia(Wikipedia)
- Q319812(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
